Zar Technology Services

opxbiotechnologies.com

At OPXBIO, we’re in the Good Chemistry business. We develop and produce bio-based chemicals and fuels that deliver more sustainable value to our customers. Good Chemistry is everything we do. It is how we use our leading EDGE™ biotechnology to bring new products to market faster. It’s our strategic partnerships. It’s our high-performing team. And it’s our inspiration to transform the business of chemistry to a more sustainable future.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Industrial Impact

GINKGO BIOWORKS AND THE RWANDA DEVELOPMENT BOARD ANNOUNCE PLANS TO DEVELOP AND IMPLEMENT NEW BIOSECURITY CAPABILITIES IN RWANDA

Ginkgo Bioworks | August 12, 2022

news image

Ginkgo Bioworks the leading horizontal platform for cell programming, and the Rwanda Development Board representing the government of the Republic of Rwanda, today announced that they have entered into a Memorandum of Understanding with the intent of developing and implementing new biosecurity capabilities in Rwanda. The initial goal of the planned partnership is to support Rwanda's public health institutions as they work to address biosecurity challenges in the region. ...

Read More

K-COSMECEUTICAL COMPANY DERMAFIRM USA, INC. OFFICIALLY ANNOUNCED ITS U.S. EXPANSION

PR Newswire | July 22, 2020

news image

Today the K-cosmeceutical company Dermafirm USA, Inc., the U.S. arm of South Korea's Dermafirm Inc., is officially announcing its U.S. expansion. Plans are to formally introduce its U.S. leadership team on July 28th, at a private, virtual event. During the event, the company will kick off a movement with a mission to embrace scientific innovation, educate consumers on clean, natural and healthy DIY skincare options and ultimately empower users to perform these skincare regimens safely at hom...

Read More

Diagnostics

BIODESIX ANNOUNCES RESEARCH AGREEMENT WITH TOP US CANCER CENTER

Biodesix | June 06, 2022

news image

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it intends to develop a new novel minimal residual disease (MRD) test as a part of a master sponsored research agreement (MSRA) with Memorial Sloan Kettering Cancer Center (MSK). In addition, the MSRA between MSK and Biodesix also includes the potential future development of other diagnostic tests aimed at improving the treatment of cancer. Read More

Industrial Impact

SENDA BIOSCIENCES BOLSTERS EXECUTIVE LEADERSHIP TEAM

Senda Biosciences | October 20, 2022

news image

Senda Biosciences, Inc., a company that is harnessing nature to program targeted, potent, and tunable medicines, today announced the appointments of Lori Rudolph-Owen, Ph.D., as Chief Operating Officer, and Barbara Bispham, J.D., as SVP, General Counsel. "We're delighted to add Lori and Barbara to the Senda leadership team as we work to build a world-class organization. Each of these seasoned executives brings the skills and experience necessary to h...

Read More
news image

Industrial Impact

GINKGO BIOWORKS AND THE RWANDA DEVELOPMENT BOARD ANNOUNCE PLANS TO DEVELOP AND IMPLEMENT NEW BIOSECURITY CAPABILITIES IN RWANDA

Ginkgo Bioworks | August 12, 2022

Ginkgo Bioworks the leading horizontal platform for cell programming, and the Rwanda Development Board representing the government of the Republic of Rwanda, today announced that they have entered into a Memorandum of Understanding with the intent of developing and implementing new biosecurity capabilities in Rwanda. The initial goal of the planned partnership is to support Rwanda's public health institutions as they work to address biosecurity challenges in the region. ...

Read More
news image

K-COSMECEUTICAL COMPANY DERMAFIRM USA, INC. OFFICIALLY ANNOUNCED ITS U.S. EXPANSION

PR Newswire | July 22, 2020

Today the K-cosmeceutical company Dermafirm USA, Inc., the U.S. arm of South Korea's Dermafirm Inc., is officially announcing its U.S. expansion. Plans are to formally introduce its U.S. leadership team on July 28th, at a private, virtual event. During the event, the company will kick off a movement with a mission to embrace scientific innovation, educate consumers on clean, natural and healthy DIY skincare options and ultimately empower users to perform these skincare regimens safely at hom...

Read More
news image

Diagnostics

BIODESIX ANNOUNCES RESEARCH AGREEMENT WITH TOP US CANCER CENTER

Biodesix | June 06, 2022

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it intends to develop a new novel minimal residual disease (MRD) test as a part of a master sponsored research agreement (MSRA) with Memorial Sloan Kettering Cancer Center (MSK). In addition, the MSRA between MSK and Biodesix also includes the potential future development of other diagnostic tests aimed at improving the treatment of cancer. Read More

news image

Industrial Impact

SENDA BIOSCIENCES BOLSTERS EXECUTIVE LEADERSHIP TEAM

Senda Biosciences | October 20, 2022

Senda Biosciences, Inc., a company that is harnessing nature to program targeted, potent, and tunable medicines, today announced the appointments of Lori Rudolph-Owen, Ph.D., as Chief Operating Officer, and Barbara Bispham, J.D., as SVP, General Counsel. "We're delighted to add Lori and Barbara to the Senda leadership team as we work to build a world-class organization. Each of these seasoned executives brings the skills and experience necessary to h...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us